. 2012 Feb 18;30(6):2411–2432. doi: 10.1007/s10637-012-9798-6
© The Author(s) 2012
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Table 1.
Pan-Aurora kinase inhibitors in clinical trials
